Carol Webb

Executive

US·SEC (Form 4)

Citius Pharmaceuticals, Inc.Citius Oncology, Inc.

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 22 Dec 2025 for CITIUS ONCOLOGY, INC.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Carol Webb: trading record in brief

Filings by Carol Webb span 2 companies, the busiest being Citius Oncology, Inc. and Citius Pharmaceuticals, Inc. Over a trading history stretching from 4 March 2024 to 19 September 2025, the count stands at 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 22 December 2025, reports a share grant in Citius Oncology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.